This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Torpy, D. J. Articles by Jackson, R. V. Search for Related Content PubMed PubMed Citation Articles by Torpy, D. J. Articles by Jackson, R. V.

Familial Corticosteroid-Binding Globulin Deficiency Due to a Novel Null Mutation: Association with Fatigue and Relative Hypotension

Department of Medicine, University of Queensland, Greenslopes Private Hospital, Brisbane, Queensland 4120, Australia; Department of Endocrinology, Queen Elizabeth Hospital (S.P.F., P.J.P.), Adelaide, South Australia 5011, Australia; John Curtin School of Medical Research (J.A.W.), Acton, Australian Capital Territory 2601, Australia

Address all correspondence and requests for reprints to: Dr. David Torpy, Department of Medicine, University of Queensland, First Floor Clinical Sciences Building, Greenslopes Private Hospital, Newdegate Street, Brisbane, Queensland 4120, Australia.

Abstract

Corticosteroid-binding globulin is a 383-amino acid glycoprotein that serves a hormone transport role and may have functions related to the stress response and inflammation. We describe a 39-member Italian-Australian family with a novel complete loss of function (null) mutation of the corticosteroid-binding globulin gene. A second, previously described, mutation (Lyon) segregated independently in the same kindred. The novel exon 2 mutation led to a premature termination codon corresponding to residue -12 of the procorticosteroid-binding globulin molecule (c.121GA). Among 32 family members there were 3 null homozygotes, 19 null heterozygotes, 2 compound heterozygotes, 3 Lyon heterozygotes, and 5 individuals without corticosteroid-binding globulin mutations. Plasma immunoreactive corticosteroid-binding globulin was undetectable in null homozygotes, and mean corticosteroid-binding globulin levels were reduced by approximately 50% at 18.7 ± 1.3 µg/ml (reference range, 30–52 µg/ml) in null heterozygotes. Morning total plasma cortisol levels were less than 1.8 µg/dl in homozygotes and were positively correlated to the plasma corticosteroid-binding globulin level in heterozygotes. Homozygotes and heterozygote null mutation subjects had a high prevalence of hypotension and fatigue. Among 19 adults with the null mutation, the systolic blood pressure z-score was 12.1 ± 3.5; 11 of 19 subjects (54%) had a systolic blood pressure below the third percentile. The mean diastolic blood pressure z-score was 18.1 ± 3.4; 8 of 19 subjects (42%) had a diastolic blood pressure z-score below 10. Idiopathic chronic fatigue was present in 12 of 14 adult null heterozygote subjects (86%) and in 2 of 3 null homozygotes. Five cases met the Centers for Disease Control criteria for chronic fatigue syndrome. Fatigue questionnaires revealed scores of 25.1 ± 2.5 in 18 adults with the mutation vs. 4.2 ± 1.5 in 23 healthy controls (P < 0.0001). Compound heterozygosity for both mutations resulted in plasma cortisol levels comparable to those in null homozygotes. Abnormal corticosteroid-binding globulin concentrations or binding affinity may lead to the misdiagnosis of isolated ACTH deficiency. The mechanism of the association between fatigue and relative hypotension is not established by these studies. As idiopathic fatigue disorders are associated with relatively low plasma cortisol, abnormalities of corticosteroid-binding globulin may be pathogenic.

This article has been cited by other articles:

				K. Wingenfeld, C. Heim, I. Schmidt, D. Wagner, G. Meinlschmidt, and D. H. Hellhammer HPA Axis Reactivity and Lymphocyte Glucocorticoid Sensitivity in Fibromyalgia Syndrome and Chronic Pelvic Pain Psychosom Med, January 1, 2008; 70(1): 65 - 72. [Abstract] [Full Text] [PDF]

				E. Crawley and G. Davey Smith Is chronic fatigue syndrome (CFS/ME) heritable in children, and if so, why does it matter? Arch. Dis. Child., December 1, 2007; 92(12): 1058 - 1061. [Full Text] [PDF]

				M. S. Cooper and P. M. Stewart Adrenal Insufficiency in Critical Illness J Intensive Care Med, November 1, 2007; 22(6): 348 - 362. [Abstract] [PDF]

				D. Qi and B. Rodrigues Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E654 - E667. [Abstract] [Full Text] [PDF]

				H. H. Petersen, T. K. Andreassen, T. Breiderhoff, J. H. Brasen, H. Schulz, V. Gross, H.-J. Grone, A. Nykjaer, and T. E. Willnow Hyporesponsiveness to glucocorticoids in mice genetically deficient for the corticosteroid binding globulin. Mol. Cell. Biol., October 1, 2006; 26(19): 7236 - 7245. [Abstract] [Full Text] [PDF]

				V. Guyonnet-Duperat, N. Geverink, G. S. Plastow, G. Evans, O. Ousova, C. Croisetiere, A. Foury, E. Richard, P. Mormede, and M.-P. Moisan Functional Implication of an Arg307Gly Substitution in Corticosteroid-Binding Globulin, a Candidate Gene for a Quantitative Trait Locus Associated With Cortisol Variability and Obesity in Pig Genetics, August 1, 2006; 173(4): 2143 - 2149. [Abstract] [Full Text] [PDF]

				O. Ousova, V. Guyonnet-Duperat, N. Iannuccelli, J.-P. Bidanel, D. Milan, C. Genet, B. Llamas, M. Yerle, J. Gellin, P. Chardon, et al. Corticosteroid Binding Globulin: A New Target for Cortisol-Driven Obesity Mol. Endocrinol., July 1, 2004; 18(7): 1687 - 1696. [Abstract] [Full Text] [PDF]

				J. M. Joyner, L. J. Hutley, A. W. Bachmann, D. J. Torpy, and J. B. Prins Greater replication and differentiation of preadipocytes in inherited corticosteroid-binding globulin deficiency Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E1049 - E1054. [Abstract] [Full Text] [PDF]

				A. J. Cleare The Neuroendocrinology of Chronic Fatigue Syndrome Endocr. Rev., April 1, 2003; 24(2): 236 - 252. [Abstract] [Full Text] [PDF]

				N. Afari and D. Buchwald Chronic Fatigue Syndrome: A Review Am J Psychiatry, February 1, 2003; 160(2): 221 - 236. [Abstract] [Full Text] [PDF]

				J.-M. Fernandez-Real, M. Pugeat, M. Grasa, M. Broch, J. Vendrell, J. Brun, and W. Ricart Serum Corticosteroid-Binding Globulin Concentration and Insulin Resistance Syndrome: A Population Study J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4686 - 4690. [Abstract] [Full Text] [PDF]